Sign in
WithdrawnNo phase

Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma

Key facts

Who runs it
West China Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
1 Jun 2025
Expected to end
30 Jul 2027
Type of study
Observational
Treatments tested
  • Not applicable- observational study
Record updated
19 August 2026
Why it stopped
Study withdrawn prior to enrollment due to administrative review

Who can take part

Age
0 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Diagnosis of medulloblastoma with documented recurrence (radiographic or histopathological confirmation)
  • Age ≤ 18 years at enrollment
  • Currently receiving active treatment for recurrent disease
  • Life expectancy ≥ 3 months
  • Primary caregiver responsible for medication administration and treatment coordination
  • Age ≥ 18 years
  • Able to read and understand study materials in [English]
  • Willing to complete study assessments

Who cannot take part

  • Child receiving exclusively palliative/hospice care
  • Parent with severe psychiatric illness or cognitive impairment preventing informed consent or questionnaire completion
  • Child enrolled in another interventional trial that would confound adherence measurement

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Children with medulloblastoma, an aggressive brain tumor, require prolonged and complex multimodal therapy. Their primary parental caregivers bear the main responsibility for ensuring treatment adherence, yet the psychological toll on these caregivers may undermine their ability to follow prescribed regimens. This study investigates whether multidimensional parental distress predicts overall treatment adherence in this population, and which specific distress domains are most strongly associated with poor adherence.

Read full original descriptionShow less

Parental distress-including depression, anxiety, and posttraumatic stress-is common among parents of children with cancer and may interfere with their ability to manage complex treatment regimens. However, no study has specifically examined whether parental distress predicts treatment adherence in children with recurrent medulloblastoma, a devastating brain tumor with a poor prognosis and no standard treatment protocol.

This prospective longitudinal cohort study aims to investigate whether parental distress is a significant predictor of treatment adherence in children with recurrent medulloblastoma. A total of 450 parent-child dyads will be enrolled across 4 tertiary pediatric oncology centers. Children must have a confirmed diagnosis of recurrent medulloblastoma and be receiving active treatment. Parents (primary caregivers) will complete validated questionnaires at baseline assessing depression, anxiety, stress, and trauma-related distress using the DASS-21 and IES-R. Treatment adherence will be monitored over a 12-month follow-up period using electronic medication monitoring caps, clinic attendance records, and parent-reported medication logs.

The primary outcome is the proportion of prescribed chemotherapy doses taken (treatment adherence rate). Secondary outcomes include trajectories of adherence over time and the relationship between specific dimensions of parental distress (depression, anxiety, stress, posttraumatic stress) and adherence patterns. The study will also examine whether child clinical factors (e.g., molecular subgroup, prior treatment history) and family demographic factors moderate this relationship.

Findings from this study may inform the development of targeted psychosocial interventions to support distressed parents and improve treatment adherence-and ultimately clinical outcomes-in this vulnerable pediatric population. Participants can expect to be enrolled in the study for approximately 12 months.

The group in the trial

  • Parent-Child Dyads with Recurrent Medulloblastoma

    Children with recurrent medulloblastoma receiving active treatment and their primary caregivers

    Treatment: Not applicable- observational study

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Parental Distress as a Predictor of Treatment Adherence in Pediatric Recurrent Medulloblastoma: A Prospective Longitudinal Cohort Study
Record updated
19 August 2026